This review discusses medicinal chemistry approaches primarily targeting HDAC1/2, LSD1, and DNMT1, with emphasis on inhibitor classes, binding mechanisms, structural features, preclinical evidence, and translational limitations, and how a better understanding of γ-globin repression may guide the development of safer an...
Mateus Mello de Souza, A. R. Pavan, Victor Gabriel de Faria Pastre et al.· European journal of medicina...· 0 citations
Artificial Intelligence (AI) has become a fundamental driver of scientific progress, particularly in disease diagnosis, drug development, and drug delivery optimization. The intersection of AI, drug design, and nanosystems for delivery is accelerating the advancement of personalized nanomedicines and innovative dianano...